Meeting Banner
Abstract #1117

Whole-Body Diffusion-Weighted Imaging at 1.5T for assessment of treatment response in non-Hodgkin lymphoma

Xiaoyi Wang1, Yanfeng Zhao1, Ning Wu1, Han Ouyang1, and Lizhi Xie2

1National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China, 2GE Healthcare, MR Research China, BeiJing, People's Republic of China

The diagnostic capability between WBDWI with contrast enhanced CT was compared in malignant lymphoma diagnosis. We found that WBDWI is a powerful tool on diagnosing non-Hodgkin(NHL) lymphoma by comparing with contrast enhanced CT. Chemotherapy causes rapid decrease of the restriction of water molecules diffusion movement, ADC-min could be valuable tools for treatment response evaluation of NHL. We recommended WBDWI examination for patients with NHL.

How to access this content:

For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.

After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.

After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.

Click here for more information on becoming a member.

Keywords